GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Amcad Biomed Corp (ROCO:4188) » Definitions » Operating Margin %

Amcad Biomed (ROCO:4188) Operating Margin % : -314.19% (As of Mar. 2025)


View and export this data going back to 2013. Start your Free Trial

What is Amcad Biomed Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Amcad Biomed's Operating Income for the three months ended in Mar. 2025 was NT$-21.30 Mil. Amcad Biomed's Revenue for the three months ended in Mar. 2025 was NT$6.78 Mil. Therefore, Amcad Biomed's Operating Margin % for the quarter that ended in Mar. 2025 was -314.19%.

Warning Sign:

Amcad Biomed Corp operating margin has been in a 5-year decline. The average rate of decline per year is -11.2%.

The historical rank and industry rank for Amcad Biomed's Operating Margin % or its related term are showing as below:

ROCO:4188' s Operating Margin % Range Over the Past 10 Years
Min: -45412.77   Med: -107.53   Max: -42.98
Current: -127.58


ROCO:4188's Operating Margin % is ranked worse than
83.19% of 815 companies
in the Medical Devices & Instruments industry
Industry Median: 2.24 vs ROCO:4188: -127.58

Amcad Biomed's 5-Year Average Operating Margin % Growth Rate was -11.20% per year.

Amcad Biomed's Operating Income for the three months ended in Mar. 2025 was NT$-21.30 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2025 was NT$-66.10 Mil.


Amcad Biomed Operating Margin % Historical Data

The historical data trend for Amcad Biomed's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amcad Biomed Operating Margin % Chart

Amcad Biomed Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -87.84 -42.98 -104.41 -82.73 -121.77

Amcad Biomed Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -245.99 -76.93 -210.07 -55.72 -314.19

Competitive Comparison of Amcad Biomed's Operating Margin %

For the Medical Devices subindustry, Amcad Biomed's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Amcad Biomed's Operating Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Amcad Biomed's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Amcad Biomed's Operating Margin % falls into.


;
;

Amcad Biomed Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Amcad Biomed's Operating Margin % for the fiscal year that ended in Dec. 2024 is calculated as

Operating Margin %=Operating Income (A: Dec. 2024 ) / Revenue (A: Dec. 2024 )
=-64.664 / 53.105
=-121.77 %

Amcad Biomed's Operating Margin % for the quarter that ended in Mar. 2025 is calculated as

Operating Margin %=Operating Income (Q: Mar. 2025 ) / Revenue (Q: Mar. 2025 )
=-21.302 / 6.78
=-314.19 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Amcad Biomed  (ROCO:4188) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Amcad Biomed Operating Margin % Related Terms

Thank you for viewing the detailed overview of Amcad Biomed's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Amcad Biomed Business Description

Traded in Other Exchanges
N/A
Address
No. 167, Fuxing North Road, 5th Floor, Zhongshan District, Taipei, TWN, 104
Amcad Biomed Corp develops computer-aided detection and diagnosis(CADe/CADx) software devices. Its product pipeline includes AmCAD-UT Detection, AmCAD-UV, AmCAD and AmCAD-UO. Geographically, the company generates revenue from Taiwan, China, Europe, Asia (excluding Taiwan and China), and other countries, out of which the majority of the revenue is generated from Taiwan. The company has two segments: the Medical Diagnostic Software segment, which is responsible for the development and sales of smart medical imaging diagnostic software devices, and the Precision Medical Equipment segment, which is responsible for research, development, manufacturing, and sales of high-end ultrasonic probes. The company generates the majority of its revenue from the Precision Medical Equipment segment.

Amcad Biomed Headlines

No Headlines